Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

The 7 Best Cheap Stocks to Buy for the Second Half of 2021

By Josh Enomoto, InvestorPlace Contributor

Although the major indices have been flying, you can’t bet on them all, which augurs well for these cheap stocks to consider.

Clover Health Might Drag Due to the ‘Free Lunch’ Problem

By Josh Enomoto, InvestorPlace Contributor

While CLOV stock enjoys a moral directive from the social media crowd, the underlying business has questionable viability.

ContextLogic Stock Could Bounce Higher Now, but Don’t Count on It

By Josh Enomoto, InvestorPlace Contributor

While WISH stock had some attributes implying a viable short-squeeze candidacy, it didn’t pan out, confirming the risks of such tactics.

Vaxart Is Gaining Relevance, But Its Future Is Still Uncertain

By Josh Enomoto, InvestorPlace Contributor

Vaxart may have a second chance at prominence with its Covid-19 vaccine pill. But VXRT stock is still a largely speculative buy.

Why Innovative Ankr Risks Getting J.P. Morgan-ed

By Josh Enomoto, InvestorPlace Contributor

While ANKR is undergirded by an extremely promising blockchain network, the sour investment market won’t cooperate.

Load More